The Effect of Combined Oral Contraceptives on the Bone Mineral Density in Perimenopausal Women
Keywords:
combined oral contraceptives; perimenopausal period; bone mineral density; metabolic syndrome; osteoporosis; osteopenia
Abstract
Increased life expectancy, lengthening of the reproductive period, early menarche and late menopause, chronic hyperestrogenism in the presence of relative or absolute progesterone deficiency, uncontrolled use of combined oral contraceptives, the formation of the metabolic syndrome are considered high-risk factors for the occurrence and progression of this pathology. Therefore, we aimed to study improvement the principles of preventing the loss and restoration of bone mineral density in women in the perimenopausal period. In women with unfavorable factors of menstrual, reproductive, somatic history in the perimenopausal period, there is a high incidence of the development of pathological decrease in bone mineral density. The use of combined oral contraceptives in the perimenopausal period contributes to the activation of bone remodeling processes.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
Published
2019-01-15
Issue
Section
License
Copyright (c) 2019 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.